- Home
- FSHP vs OVID Comparison
FSHP vs OVID Comparison
Compare FSHP & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSHP
- OVID
- Stock Information
- Founded
- FSHP 2018
- OVID 2014
- Country
- FSHP United States
- OVID United States
- Employees
- FSHP N/A
- OVID N/A
- Industry
- FSHP
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- FSHP
- OVID Health Care
- Exchange
- FSHP NYSE
- OVID Nasdaq
- Market Cap
- FSHP 89.2M
- OVID 85.2M
- IPO Year
- FSHP 2024
- OVID 2017
- Fundamental
- Price
- FSHP $10.15
- OVID $1.17
- Analyst Decision
- FSHP
- OVID Strong Buy
- Analyst Count
- FSHP 0
- OVID 5
- Target Price
- FSHP N/A
- OVID $4.04
- AVG Volume (30 Days)
- FSHP 5.1K
- OVID 202.6K
- Earning Date
- FSHP 01-01-0001
- OVID 11-12-2024
- Dividend Yield
- FSHP N/A
- OVID N/A
- EPS Growth
- FSHP N/A
- OVID N/A
- EPS
- FSHP N/A
- OVID N/A
- Revenue
- FSHP N/A
- OVID $631,695.00
- Revenue This Year
- FSHP N/A
- OVID $21.51
- Revenue Next Year
- FSHP N/A
- OVID $7,300.79
- P/E Ratio
- FSHP $216.10
- OVID N/A
- Revenue Growth
- FSHP N/A
- OVID 113.21
- 52 Week Low
- FSHP $9.99
- OVID $0.68
- 52 Week High
- FSHP $10.15
- OVID $4.10
- Technical
- Relative Strength Index (RSI)
- FSHP N/A
- OVID 51.44
- Support Level
- FSHP N/A
- OVID $1.13
- Resistance Level
- FSHP N/A
- OVID $1.47
- Average True Range (ATR)
- FSHP 0.00
- OVID 0.10
- MACD
- FSHP 0.00
- OVID 0.00
- Stochastic Oscillator
- FSHP 0.00
- OVID 32.43
About FSHP FLAG SHIP ACQUISITION CORPORATION
Flag Ship Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.